Avanos Medical (AVNS) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $34.4 million.
- Avanos Medical's Accumulated Depreciation & Amortization fell 57.8% to $34.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $34.4 million, marking a year-over-year decrease of 57.8%. This contributed to the annual value of $46.1 million for FY2023, which is 335.43% down from last year.
- Per Avanos Medical's latest filing, its Accumulated Depreciation & Amortization stood at $34.4 million for Q3 2024, which was down 57.8% from $22.7 million recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Accumulated Depreciation & Amortization registered a high of $47.7 million during Q4 2022, and its lowest value of $9.7 million during Q1 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $26.5 million, with a median of $23.6 million in 2023.
- As far as peak fluctuations go, Avanos Medical's Accumulated Depreciation & Amortization surged by 2662.72% in 2020, and later crashed by 1072.26% in 2021.
- Avanos Medical's Accumulated Depreciation & Amortization (Quarter) stood at $42.9 million in 2020, then dropped by 10.72% to $38.3 million in 2021, then grew by 24.54% to $47.7 million in 2022, then decreased by 3.35% to $46.1 million in 2023, then fell by 25.38% to $34.4 million in 2024.
- Its last three reported values are $34.4 million in Q3 2024, $22.7 million for Q2 2024, and $11.4 million during Q1 2024.